S Procurement Jobs In Basel Bs - 57 Job Positions Available

JOB DESCRIPTION: At Abbott, we help people live healthier, fuller lives — physically, emotionally, and socially. As a global healthcare leader with more than 107,000 employees across 160+ countries, we develop breakthrough technologies and solutions that

Company Description Turner & Townsend is a global professional services company with over 22,000 people in more than 60 countries. Working with our clients across real estate, infrastructure, energy and natural resources, we transform together delivering

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)

The actual location of this job is in Basel, Switzerland. Relocation assistance is available for eligible candidates and their families, if needed. https://www.youtube.com/watch?v=OBoAVhfTkTQ What you will get: · An agile career and a dynamic work culture

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,

Company Description At Sobi, the work we do every day redefines the standards of care and transform the lives of people living with rare diseases. As a diverse team of entrepreneurial people, we are passionate about

The Botnar Institute of Immune Engineering (BIIE) is looking for a Lab Support & Operations Coordinator to join its Research Operations team. This is a practical role within the support network available to all BIIE laboratory

The Botnar Institute of Immune Engineering (BIIE) is a new interdisciplinary research institute dedicated to innovation in immune engineering. Founded in 2024 through a generous endowment from Fondation Botnar, the BIIE supports scientists in taking on

BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)

The actual location of this job is in Basel Tower, Switzerland. As Global Category Manager Laboratory Supplies, you will play a key role in shaping global sourcing strategies that support research, development and manufacturing activities across

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,

Role overview We are looking for a pragmatic IT Business Analyst with a strong interest in technology cost management, portfolio planning, and data-driven decision-making. You will work alongside IT leaders, product and delivery teams to make

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)